Phase 3 RCT in patients with acute trigeminal neuralgia exacerbations (21 analysed): IV fosphenytoin reduced pain at 120 minutes vs placebo (NRS change -6.1 v -2.4; difference -3.8). Adverse events were mild and transient; small sample, findings preliminary.
RCTn = 22
Noro et al. IV Fosphenytoin for Acute Trigeminal Neuralgia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial